Fundraising FoxUNCOMMON DENOMINATOR — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Mytide Therapeuticsmytide.ioDec 2022 · $7M
BiotechBoston, US
Dale Thomas(Mr. Thomas is the President of the Issuer.)Jason Norris(Mr. Norris is the Treasurer and Secretary of the Issuer.)inErrik Anderson(Director)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.